"Apomorphine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use.
Descriptor ID |
D001058
|
MeSH Number(s) |
D03.132.098.038.290 D03.633.100.531.085.030.290 D03.633.400.095.290
|
Concept/Terms |
Apomorphine Hydrochloride, Anhydrous- Apomorphine Hydrochloride, Anhydrous
- Anhydrous Apomorphine Hydrochloride
- Hydrochloride, Anhydrous Apomorphine
- Apomorphine Hydrochloride Anhydrous
- Anhydrous, Apomorphine Hydrochloride
- Hydrochloride Anhydrous, Apomorphine
Apomorphine Hydrochloride- Apomorphine Hydrochloride
- Hydrochloride, Apomorphine
- Apomorphine Hydrochloride, Hemihydrate
- Hemihydrate Apomorphine Hydrochloride
- Hydrochloride, Hemihydrate Apomorphine
|
Below are MeSH descriptors whose meaning is more general than "Apomorphine".
Below are MeSH descriptors whose meaning is more specific than "Apomorphine".
This graph shows the total number of publications written about "Apomorphine" by people in this website by year, and whether "Apomorphine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2018 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Apomorphine" by people in Profiles.
-
Apomorphine infusion in advanced Parkinson disease. Nat Rev Neurol. 2018 Dec; 14(12):693-694.
-
[Duodenale levodopa and apomorphine infusion for motor complications in advanced Parkinson's disease]. Fortschr Neurol Psychiatr. 2018 09; 86(S 01):S5-S9.
-
Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease. J Neural Transm (Vienna). 2018 08; 125(8):1131-1135.
-
Caregiver burden and its related factors in advanced Parkinson's disease: data from the PREDICT study. J Neurol. 2018 May; 265(5):1124-1137.
-
Development of a high-throughput fluorescence polarization assay for the discovery of EZH2-EED interaction inhibitors. Acta Pharmacol Sin. 2018 Feb; 39(2):302-310.
-
Apomorphine and levodopa challenge in patients with a focal midbrain lesion. Mov Disord. 1999 Mar; 14(2):269-75.